Navigation Links
Oncothyreon announces webcast of second quarter 2009 financial results conference call
Date:8/6/2009

SEATTLE, Aug. 6 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its second quarter and year end 2009 financial results on Wednesday, August 12, 2009 after the close of the U.S. and Canadian markets. Following the release, Oncothyreon's management expects to discuss these financial results and give a general business update in a conference call at 4:30 p.m. EST.

The discussion is planned for a live webcast and can be accessed at www.oncothyreon.com under the "News Events" section. It is expected that the archive of the webcast will be available approximately one hour after completion of the discussion and will be posted on the Oncothyreon website for 30 days.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
2. Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
3. Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
4. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
5. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
6. Oncothyreon announces closing of $11.1 million registered direct financing
7. Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
8. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
9. Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
10. Oncothyreon reports first quarter 2009 financial results
11. Oncothyreon regains compliance with NASDAQ listing requirements

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...swire/ -- Nearly 600 medical research executives, ...ned to explore novel development approaches and in...nering for Cures meeting. ,, FasterCures, t..., convened Partnering for Cures to facilitate mu...fic discovery into an accessible therapy. This ef...
(Date:12/2/2009)... , - "Bolstering Biodivers..., Coinciding with the International Year of... is hosting an international conference in Librevi...l resources in Africa. The,conference will be atte...cientific experts, private companies, representati...
(Date:12/2/2009).../ -- S*BIO Pte Ltd today announced data presentati...he American Society of Hematology 51st Annual Meet... be presented on the clinical results from the Pha... safety, tolerability and pharmacokinetic/pharmaco...m 100 to 600 mg. These doses were administered onc...
(Date:12/2/2009)...-Asia/ -- The world is going through,extraordinary...part of many,businesses and industries. It turns o...mune to the economic downturn, because illness doe...of the difficult times this year, the pharmaceutic...p;D center in Shanghai, the largest of,its kind in...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...national investigation involving the participation...icas (CSIC) has reproduced the experiment of Thoma...lecular system that exists. In 1803 the English sc... from a distant source, on passing through a doubl...irmed the theory that light had wave motion proper...
...a., Nov. 15 With its warm business climate,and ap... the nation,s,leading technology states. Statewid... jobs in,2005, reaching a total of 276,400 jobs, a...ort by the American Electronics Association (AeA) ... a 4 percent growth rate in tech jobs, Florida was...
...d., Nov. 15 Martek Biosciences,Corporation (Nasda...ision of,the European Patent Office (EPO) has rule...,s European docosahexaenoic acid (DHA) patents. Th...the claims originally,granted but broader than the...2000 Opposition Division hearing. The patent, whic...
Other Biology Technology:Young's experiment in a hydrogen molecule 2Florida's Technology Sector Attracting Skilled Workers Needing Homes 2European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed 2European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed 3
(Date:12/2/2009)...A People who smoke their first cigarette within m...cotinine, a by-product of nicotine when processed ...ess of the number of cigarettes smoked. , "Si...lung cancer, our results suggest that smokers who ...t risk for lung cancer," said researcher Joshua E....
(Date:12/2/2009)... Ind. ╤ A Smoky Mountain forest,s woodland h...ole in how forest understories recover from loggin...spite heavy logging in portions of the forest near...ts on the secondary forest floor was similar to th... assistant professor of forestry and natural resou...
(Date:12/2/2009)...uke University Medical Center researchers have fig...cer glioma may be better able to resist radiation ...gnaling pathway in these cancer stem cells, they w...tion in a laboratory experiment. , The work bui...stem cells resist the effects of radiation much be...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Study finds logging effects vary based on a forest's history, climate 2Discovery makes brain tumor cells more responsive to radiation 2Life on Earth came from other planets 9299 1Life on Earth came from other planets 9299 2Life on Earth came from other planets 9299 3Life on Earth came from other planets 9299 4International research team seeks to unravel flatworm regeneration 9296 1International research team seeks to unravel flatworm regeneration 9296 2New research finds possible genetic link to cause of pregnancy loss and disorders 9293 1New research finds possible genetic link to cause of pregnancy loss and disorders 9293 2
...searchers at Duke University Medical Center and th...mice how a single disrupted gene can cause a form ...drome. , In a study published in the journal N...3A, is needed so that neurons in the brain can fo...or storing sensory information. They also made a ...
...rsity of Alabama at Birmingham professor of pathol...or Outstanding Innovation in Life Sciences. The p... Weaver,s achievements in advancing understanding ...cell research. , According to Weaver, our bodies...cer, but when T cells overreact and turn on the bo...
...Harrison has been awarded the Society for Pediatr...nguished Service Award. , Demmler-Harrison, direc... Hospital and professor of Pediatrics at Baylor Co...t Pediatric Academic Societies, Annual Meeting in ... American Pediatric Society, Society for Pediatric...
Other Biology News:Preclinical work shows how one gene causes severe mental retardation 2Preclinical work shows how one gene causes severe mental retardation 3UAB professor receives HudsonAlpha Innovation Prize 2
...fer true walk-away automation of magnetic cell sep...solate cells by either positive or negative select...s at one time. RoboSep is easily controlled via a ...nterface makes it simple and fast to set up your c...
... purified RNA samples., , This product has bee...amples that have been pre-purified using tradition...ilica, oligo dT etc or other kits. , Our StabMRT... stabilization of nanogram to milligram quantities...
...ed RNA samples for RT-PCR and microarray analysis....es and applications you expect from our StabMRT Ki...ic applications such as RT-PCR and microarrays.,...lization of aqueous RNA samples that have been pre...
pORF39-Bsr from InvivoGen
Biology Products: